Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system

Objectives: This study summarizes passive surveillance data for adverse events following immunization (AEFI) in Zhejiang province. Methods: The AEFI reports and number of doses on all vaccines used were extracted from the national AEFI surveillance system and the immunization information system of Z...

Full description

Bibliographic Details
Main Authors: Xuejiao Pan, Huakun Lv, Fuxing Chen, Ying Wang, Hui Liang, Linzhi Shen, Yaping Chen, Yu Hu
Format: Article
Language:English
Published: Taylor & Francis Group 2021-10-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2021.1939621
_version_ 1827807031966302208
author Xuejiao Pan
Huakun Lv
Fuxing Chen
Ying Wang
Hui Liang
Linzhi Shen
Yaping Chen
Yu Hu
author_facet Xuejiao Pan
Huakun Lv
Fuxing Chen
Ying Wang
Hui Liang
Linzhi Shen
Yaping Chen
Yu Hu
author_sort Xuejiao Pan
collection DOAJ
description Objectives: This study summarizes passive surveillance data for adverse events following immunization (AEFI) in Zhejiang province. Methods: The AEFI reports and number of doses on all vaccines used were extracted from the national AEFI surveillance system and the immunization information system of Zhejiang province (ZJIIS). Reporting rates of AEFI were calculated by age, city, severity of AEFI, categories of AEFI, vaccine types, and reaction categories. Results: A total of 13,079 AEFI records were reported and 23,091,401 vaccine doses were administered, with a reporting rate of 56.64/100,000 doses for AEFI. The highest reporting rate of AEFI was observed among the infants <1 year of age (108.61/100,000 doses) and the lowest rate was observed among recipients aged ≥60 years. Most of the AEFI reports were vaccine product-related reactions (48.81/100,000 doses), and the lowest was vaccination errors (0.02/100,000 doses). The most frequently reported individual vaccine was DTP and Hib combined vaccine, with a reporting rate of 426.62/100,000 doses. The most frequently reported AEFI was fever/redness/induration (48.82/100,000 doses). Conclusion: Our findings illustrated the high level of vaccine safety since the majority of those reported were not serious, or coincidentally associated with vaccination. Furthermore, the national AEFI surveillance system should be continuously used as a surveillance tool for monitoring of AEFI.
first_indexed 2024-03-11T21:51:12Z
format Article
id doaj.art-2b775e0f1c524ed1996a1977b29377f9
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:51:12Z
publishDate 2021-10-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-2b775e0f1c524ed1996a1977b29377f92023-09-26T08:59:29ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2021-10-0117103823383010.1080/21645515.2021.19396211939621Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance systemXuejiao Pan0Huakun Lv1Fuxing Chen2Ying Wang3Hui Liang4Linzhi Shen5Yaping Chen6Yu Hu7Institute of Immunization and PreventionInstitute of Immunization and PreventionInstitute of Immunization and PreventionInstitute of Immunization and PreventionInstitute of Immunization and PreventionInstitute of Immunization and PreventionInstitute of Immunization and PreventionInstitute of Immunization and PreventionObjectives: This study summarizes passive surveillance data for adverse events following immunization (AEFI) in Zhejiang province. Methods: The AEFI reports and number of doses on all vaccines used were extracted from the national AEFI surveillance system and the immunization information system of Zhejiang province (ZJIIS). Reporting rates of AEFI were calculated by age, city, severity of AEFI, categories of AEFI, vaccine types, and reaction categories. Results: A total of 13,079 AEFI records were reported and 23,091,401 vaccine doses were administered, with a reporting rate of 56.64/100,000 doses for AEFI. The highest reporting rate of AEFI was observed among the infants <1 year of age (108.61/100,000 doses) and the lowest rate was observed among recipients aged ≥60 years. Most of the AEFI reports were vaccine product-related reactions (48.81/100,000 doses), and the lowest was vaccination errors (0.02/100,000 doses). The most frequently reported individual vaccine was DTP and Hib combined vaccine, with a reporting rate of 426.62/100,000 doses. The most frequently reported AEFI was fever/redness/induration (48.82/100,000 doses). Conclusion: Our findings illustrated the high level of vaccine safety since the majority of those reported were not serious, or coincidentally associated with vaccination. Furthermore, the national AEFI surveillance system should be continuously used as a surveillance tool for monitoring of AEFI.http://dx.doi.org/10.1080/21645515.2021.1939621aefi (adverse events following immunization)surveillancevaccinationvaccine safety
spellingShingle Xuejiao Pan
Huakun Lv
Fuxing Chen
Ying Wang
Hui Liang
Linzhi Shen
Yaping Chen
Yu Hu
Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
Human Vaccines & Immunotherapeutics
aefi (adverse events following immunization)
surveillance
vaccination
vaccine safety
title Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
title_full Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
title_fullStr Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
title_full_unstemmed Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
title_short Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
title_sort analysis of adverse events following immunization in zhejiang china 2019 a retrospective cross sectional study based on the passive surveillance system
topic aefi (adverse events following immunization)
surveillance
vaccination
vaccine safety
url http://dx.doi.org/10.1080/21645515.2021.1939621
work_keys_str_mv AT xuejiaopan analysisofadverseeventsfollowingimmunizationinzhejiangchina2019aretrospectivecrosssectionalstudybasedonthepassivesurveillancesystem
AT huakunlv analysisofadverseeventsfollowingimmunizationinzhejiangchina2019aretrospectivecrosssectionalstudybasedonthepassivesurveillancesystem
AT fuxingchen analysisofadverseeventsfollowingimmunizationinzhejiangchina2019aretrospectivecrosssectionalstudybasedonthepassivesurveillancesystem
AT yingwang analysisofadverseeventsfollowingimmunizationinzhejiangchina2019aretrospectivecrosssectionalstudybasedonthepassivesurveillancesystem
AT huiliang analysisofadverseeventsfollowingimmunizationinzhejiangchina2019aretrospectivecrosssectionalstudybasedonthepassivesurveillancesystem
AT linzhishen analysisofadverseeventsfollowingimmunizationinzhejiangchina2019aretrospectivecrosssectionalstudybasedonthepassivesurveillancesystem
AT yapingchen analysisofadverseeventsfollowingimmunizationinzhejiangchina2019aretrospectivecrosssectionalstudybasedonthepassivesurveillancesystem
AT yuhu analysisofadverseeventsfollowingimmunizationinzhejiangchina2019aretrospectivecrosssectionalstudybasedonthepassivesurveillancesystem